Report copyright - WHO Pharmaceuticals NEWSLETTERWHO Pharmaceuticals Newsletter No. 1, 2016 5 Regulatory Matters Amlodipine besilate Risk of fulminant hepatitis, agranulocytosis and rhabdomyolysis Japan
Please pass captcha verification before submit form